Company · CIK 0000109657 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GT Biopharma, Inc. · GTBP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2019 SForm 4 → | Feb 13, 11:22 am EST | Tony CataldoDirector | 800,000 | $0.001 | $800 | 4,029,600 | −16.6% | plan? late |
| Sep 1, 2017 AGForm 4 → | Dec 1, 7:12 pm EST | Tony CataldoExecutive Chairman, Director, 10% Owner | 8,429,660 | — | — | 1,843,029 | — | plan? late |
| Sep 1, 2017 AForm 4 → | Dec 1, 5:17 pm EST | Steven W WeldonCFO, Director | 2,566,835 | — | — | 2,568,840 | — | plan? late |
| Apr 5, 2016 JForm 4 → | Apr 5, 6:05 pm EDT | BRISTOL INVESTMENT FUND LTD10% Owner | 250,000 | — | — | 463,806 | — | plan? |
| Apr 4, 2016 SForm 4 → | Apr 5, 6:05 pm EDT | BRISTOL INVESTMENT FUND LTD10% Owner | 675,000 | $303,750.00 | $205,031,250,000 | 1,525,472 | −30.7% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.